Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oligodendrocyte transcription factor 2 (OLIG2)
- Target
- OLIG2
- Molecular classification
- Transcription factor, bHLH family
01
Overview
OLIG2 is a basic helix-loop-helix (bHLH) transcription factor crucial for central nervous system development. It specifies cell fate among neural progenitors, directing the differentiation of oligodendrocytes and specific types of neurons. OLIG2 plays a role in maintaining progenitor cell pools and is regulated by phosphorylation. Its dysregulation is implicated in neurodevelopmental disorders and brain cancers like glioblastoma multiforme.
02
Biological functions
Neural DevelopmentMotor neuron differentiationOligodendrocyte differentiationProgenitor cell maintenanceRegulation of gene expressionChromatin remodeling
03
Disease associations
Neurodevelopmental disordersGlioblastoma multiformeSchizophrenia (ethnicity-dependent)
Beyond the preview
Go deeper on Oligodendrocyte transcription factor 2 (OLIG2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Follow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Compare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Investigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Explore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Connect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oligodendrocyte transcription factor 2 (OLIG2).